Hamel Associates, Inc. Amgen Inc Transaction History

Hamel Associates, Inc.

$295 Million
Q2 2025

A detailed history of Hamel Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hamel Associates, Inc. holds 19,632 shares of AMGN stock, worth $5.8 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares

19,632

Previous 17,771 10.47%

Holding current value

$5.8 Million

Previous $5.54 Million 0.99%

% of portfolio

1.86%

Previous 1.88%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$262.28 - $309.85 $488,103 - $576,630	1,861 Added 10.47%	19,632 $5.48 Million
Q1 2025 May 06, 2025	BUY	$258.59 - $327.36 $265,054 - $335,544	1,025 Added 6.12%	17,771 $5.54 Million
Q4 2024 Feb 05, 2025	SELL	$258.78 - $328.31 $64,177 - $81,420	-248 Reduced 1.46%	16,746 $4.36 Million
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $31,247 - $34,075	-101 Reduced 0.59%	16,994 $5.48 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $788 - $957	-3 Reduced 0.02%	17,095 $5.34 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $93,330 - $105,287	365 Added 2.18%	17,098 $4.92 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $47,009 - $58,363	215 Added 1.3%	16,733 $4.5 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $645,381 - $763,150	3,012 Added 22.3%	16,518 $3.67 Million
Q1 2023 May 08, 2023	BUY	$225.79 - $275.2 $29,804 - $36,326	132 Added 0.99%	13,506 $3.27 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $39,280 - $44,301	-175 Reduced 1.29%	13,374 $3.01 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $13,842 - $15,404	-60 Reduced 0.44%	13,549 $3.3 Million
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $107,223 - $118,616	489 Added 3.73%	13,609 $3.29 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $412,676 - $472,270	2,075 Added 18.79%	13,120 $2.95 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $203,779 - $238,752	960 Added 9.52%	11,045 $2.35 Million
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $58,395 - $64,785	-250 Reduced 2.42%	10,085 $2.46 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $124,269 - $144,816	560 Added 5.73%	10,335 $2.57 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $5,409 - $6,441	-25 Reduced 0.26%	9,775 $2.25 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $59,228 - $78,552	325 Added 3.43%	9,800 $1.99 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $383,410 - $449,443	2,300 Added 32.06%	9,475 $1.75 Million
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $533,566 - $601,446	2,950 Added 69.82%	7,175 $1.36 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $8,920 - $10,412	50 Added 1.2%	4,225 $822,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $20,756 - $23,313	-125 Reduced 2.91%	4,175 $771,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,300	4,300 $741,000

Others Institutions Holding AMGN

# of Institutions

3,274

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account

Hamel Associates, Inc. Amgen Inc Transaction History